Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection

Programmed death-ligand 1 (PD-L1) plays an essential protein for immune evasion, contributing to tumor development and progression. Recent studies have reported MET as an upregulator for PD-L1 overexpression through an oncogenic pathway. However, an association between PD-L1 expression with MET has...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Kwon, Mi Jung, Kim, Kab-Choong, Nam, Eun Sook, Cho, Seong Jin, Park, Hye-Rim, Min, Soo Kee, Seo, Jinwon, Choe, Ji-Young, Lee, Hye Kyung, Kang, Ho Suk, Min, Kyueng-Whan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2017
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5669899/
https://ncbi.nlm.nih.gov/pubmed/29137273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19390
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items